[ Price : $8.95]
Janssen says results of a head-to-head trial showed its Spravato had superior efficacy to Seroquel in patients with treatment-resi...[ Price : $8.95]
Three Ropes & Gray attorneys describe some of the issues in a long-awaited FDA final guidance on clinical decision support softwar...[ Price : $8.95]
FDA probes the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients treated with Am...[ Price : $8.95]
Federal Register notice: FDA is identifying two bulk drug substances that it has considered and proposes to include on its list of...[ Price : $8.95]
The FDA Modeling and Simulation Working Group issues a report on how modeling and simulation are used within and across FDA Center...[ Price : $8.95]
At FDAs request, GSK is withdrawing the accelerated approval for Blenrep (belantamab mafodotin-blmf) due to the therapys poor show...[ Price : $8.95]
FDA warns Lake Forest, CA-based Invitrx Therapeutics about illegally marketing cellular and acellular products and CGMP and CGTP v...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Compounding Certain Beta-Lactam Products in Shortage Under ...